Form 4: Quest Diagnostics CEO James E. Davis Reports Stock Disposals to Cover Tax Obligations
SEC Form 4 Filing
CEO James E. Davis of Quest Diagnostics reports disposing of common stock to cover tax obligations arising from vested restricted share units.
Summary
- On February 28, 2024, James E. Davis, CEO and President of Quest Diagnostics, reported the disposal of 3,216 shares of common stock at a price of $126.36.
- Additionally, Davis disposed of 1,804 shares of common stock at the same price.
- These transactions were executed to satisfy tax obligations related to the vesting of previously granted restricted share units.
- Following these transactions, Davis directly owns 125,968 shares of Quest Diagnostics common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing simply reports stock disposals for tax purposes, which is a routine event. There's no indication of positive or negative sentiment towards the company's prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Disposals to cover tax obligations are common and don't necessarily indicate a negative outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of stock disposal transactions. |
| 03/01/2024 | Date of signature by Attorney in Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.